Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer

被引:19
作者
Kim, Josephine S. [1 ,2 ]
Mills, Kathryn A. [1 ,2 ]
Fehniger, Julia [1 ,2 ]
Liao, Chuanhong [3 ]
Hurteau, Jean A. [2 ]
Kirschner, Carolyn V. [2 ]
Lee, Nita K. [1 ]
Rodriguez, Gustavo C. [2 ]
Yamada, S. Diane [1 ]
Moore, Elena S. Diaz [2 ]
Tenney, Meaghan E. [1 ]
机构
[1] Univ Chicago Med, Dept Obstet & Gynecol, Sect Gynecol Oncol, Chicago, IL USA
[2] NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Div Gynecol Oncol, Evanston, IL USA
[3] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA
关键词
endometrial cancer; venous thromboembolism; robotic hysterectomy; MINIMALLY INVASIVE SURGERY; GYNECOLOGIC-ONCOLOGY; WOMEN; HYSTERECTOMY; PREVENTION; SOCIETY; RISK;
D O I
10.1097/IGC.0000000000001084
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This study aims to determine the rate of postoperative venous thromboembolism (VTE) in endometrial cancer patients undergoing robotic hysterectomy with or without extended pharmacologic VTE prophylaxis. Methods/Materials: A retrospective chart review of women undergoing robotic hysterectomy with or without other procedures for endometrial cancer from January 2010 to February 2015 was conducted at 2 institutions. Charts were manually abstracted, and rates of VTE within 30 and 60 days after surgery were determined. Patients were then stratified by those who did and did not receive extended VTE prophylaxis. Results: A total of 403 patients were included, of which 367 patients (91%) received extended pharmacologic prophylaxis and 36 patients (9%) did not. Low molecular weight heparin prescriptions ranged from 7 to 30 days. Patients receiving extended prophylaxis (EP) were older (63 +/- 11 vs 57 +/- 12; P = 0.004), more frequently underwent lymphadenectomy (67% vs 34%; P G 0.001), and had higher-grade tumors compared with patients not receiving EP. Overall 30-day and 60-day VTE rates were 0.7% and 1.2%, respectively. There were no significant differences in 30-day and 60-day VTE rates among patients that did and did not receive EP, although a trend toward lower VTE rates in the EP group was observed (30-day rates 0.5% vs 2.8% respectively, P = 0.25; 60-day rates 0.8% vs 5.6%, P = 0.07). Conclusions: In this study, 30-day and 60-day VTE rates after minimally invasive surgery for endometrial cancer were low. Rates were also similar to those of previous reports in this setting in which the majority of patients did not receive extended VTE prophylaxis. Given the consistent finding that postoperative VTE in this population is rare regardless of prophylaxis use and the variability in practice patterns for VTE prophylaxis, the development of best practice guidelines for EP use specific to this setting is warranted.
引用
收藏
页码:1774 / 1782
页数:9
相关论文
共 23 条
  • [1] Prevention of venous thromboembolism in surgical patients
    Agnelli, G
    [J]. CIRCULATION, 2004, 110 (24) : 4 - 12
  • [2] Barber EL, 2016, AM J OBSTET GYNECOL, V215
  • [3] Prevention of venous thromboembolism in gynecologic oncology surgery
    Barber, Emma L.
    Clarke-Pearson, Daniel L.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 144 (02) : 420 - 427
  • [4] Venous Thromboembolism in Minimally Invasive Compared With Open Hysterectomy for Endometrial Cancer
    Barber, Emma L.
    Gehrig, Paola A.
    Clarke-Pearson, Daniel L.
    [J]. OBSTETRICS AND GYNECOLOGY, 2016, 128 (01) : 121 - 126
  • [5] Venous Thromboembolism A Public Health Concern
    Beckman, Michele G.
    Hooper, W. Craig
    Critchley, Sara E.
    Ortel, Thomas L.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2010, 38 (04) : S495 - S501
  • [6] Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
    Bergqvist, D
    Agnelli, G
    Cohen, AT
    Eldor, A
    Nilsson, PE
    Le Moigne-Amrani, A
    Dietrich-Neto, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) : 975 - 980
  • [7] Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?
    Bouchard-Fortier, Genevieve
    Geerts, William H.
    Covens, Allan
    Vicus, Danielle
    Kupets, Rachel
    Gien, Lilian T.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 228 - 232
  • [8] Cancer-Associated Venous Thromboembolic Disease, 2015, NCCN CLIN PRACTICE G, V1
  • [9] THE NATURAL-HISTORY OF POSTOPERATIVE VENOUS THROMBOEMBOLI IN GYNECOLOGIC ONCOLOGY - A PROSPECTIVE-STUDY OF 382 PATIENTS
    CLARKEPEARSON, DL
    SYNAN, IS
    COLEMEN, E
    HINSHAW, W
    CREASMAN, WT
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 148 (08) : 1051 - 1054
  • [10] Committee on Practice Bulletins-Gynecology American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P429